Parkinson's psychosis drug shows promise in final trial

NCT ID NCT06068465

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tested whether the drug pimavanserin can safely reduce hallucinations and delusions in people with Parkinson's disease psychosis. 248 participants took either the drug or a placebo daily for 6 weeks. The main goal was to see if symptoms improved, measured by a standard rating scale.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance

pimavanserin (also known as NUPLAZID)

What this could lead to

If it works, this could provide a treatment option to ease hallucinations and delusions in people with Parkinson's disease.

What could go wrong

This is a completed phase 3 trial, but results are not yet published. The drug may not prove more effective than placebo, and side effects are possible.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for PARKINSON'S DISEASE PSYCHOSIS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Beijing Hospital

    Beijing, Beijing Municipality, 100005, China

  • Guangdong Provincial Peoples Hospital

    Guangzhou, Guangdong, 510000, China

  • Huai'an Second People's Hospital

    Huaian, Jiangsu, 223022, China

  • Inner Mongolia Autonomous Region People's Hospital

    Hohhot, Inner Mongolia, 010000, China

  • Mianyang Central Hospital

    Mianyang, Sichuan, 621099, China

  • Nanjing Drum Tower Hospital

    Nanjing, Jiangsu, 210008, China

  • Peking University Sixth Hospital

    Beijing, Beijing Municipality, 100191, China

  • People's Hospital of Ningxia Hui Autonomous Region

    Yinchuan, Ningxia, 750002, China

  • Qilu Hospital of Shandong University

    Jinan, Shandong, 250012, China

  • Qilu Hospital of Shandong University(Qingdao)

    Qingdao, Shandong, 266035, China

  • Ruijin Hospital

    Shanghai, Shanghai Municipality, 200025, China

  • The Affiliated Hospital of Guizhou Medical University

    Guiyang, Guizhou, 550001, China

  • The Affiliated Hospital of Xuzhou Medical University

    Xuzhou, Jiangsu, 221004, China

  • The First Affiliated Hospital of Anhui Medical University

    Hefei, Anhui, 230061, China

  • The First Affiliated Hospital of Chongqing Medical University

    Chongqing, Chongqing Municipality, 400016, China

  • The First Affiliated Hospital of Fujian Medical University

    Fuzhou, Fujian, 350005, China

  • The First Affiliated Hospital of Zhengzhou University

    Zhengzhou, Henan, 450052, China

  • The First Hospital of China Medical University

    Shenyang, Liaoning, 110002, China

  • The First Hospital of Jilin University

    Changchun, Jilin, 130021, China

  • The Second Affiliated Hospital of Nanchang University

    Nanchang, Jiangxi, 330008, China

  • The Second Affiliated Hospital of Soochow University

    Suzhou, Jiangsu, 215004, China

  • The Second Hospital of HeBei Medical University

    Shijiazhuang, Hebei, 050005, China

  • The Third Xiangya Hospital of Central South University

    Changsha, Hunan, 410013, China

  • Tianjin Huanhu Hospital

    Tianjin, Tianjin Municipality, 300222, China

  • West China Hospital of Sichuan University

    Chengdu, Sichuan, 610041, China

  • Xuan Wu Hospital

    Beijing, Beijing Municipality, 100053, China

  • Zhongda Hospital Southeast University

    Nanjing, Jiangsu, 210009, China